A Very Long-acting Exatecan and Its Synergism with DNA Damage Response Inhibitors.

Cancer research communications（2023）

引用 0|浏览4

暂无评分

摘要

A circulating conjugate that slowly releases Exa is described. It is efficacious after a single dose and synergistic with ATR and PARP inhibitors.

查看译文

关键词

exatecan,dna damage response,inhibitors,long-acting

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要